Our Very First Stock Pick Is Up 686% – and There's More to Come

It was the first stock we recommended on the first day Private Briefing was published.

And that stock hit a new multiyear high today - and is now up 686%.

The company I'm talking about is biotech Galapagos NV (Nasdaq ADR: GLPG). We first recommended shares of the Belgian biotech at $8.60 each back in mid-August 2011. And we've re-recommended it more than a dozen times since then.

Leave a Reply

Your email address will not be published. Required fields are marked *


Some HTML is OK